Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5

Although early switching yields the greatest visual improvement and faster rehabilitation, it incurs higher costs. The no-switch strategy provided modest visual improvement at the lowest cost, resulting in the most favourable cost-effectiveness ratio. Late switching produced limited benefit at high cost, rendering it an unfavourable option. Treatment decisions should balance clinical efficacy and cost-effectiveness on an individual basis.

Authors

Institutions

Publication Details

Journal
Clinical and Experimental Optometry
Published
2026-01-05
DOI
https://doi.org/10.1080/08164622.2025.2601290
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5

Abdullah Özkaya, Dilan Yıldız, Mehmet Erdoğan, Gamze Karataş et al.
Clinical and Experimental Optometry
Retinal Diseases and Treatments
article

Cost-effectiveness analysis of early versus late switching in treatment-naïve patients with refractory diabetic macular oedema in the Turkish population: real-world data from the Bosphorus DME study group, report number 5

Abdullah Özkaya, Dilan Yıldız, Mehmet Erdoğan, Gamze Karataş, Bengi Demirayak, Mine Öztürk, Semra Tiryaki Demir, İlke Onur, Mustafa Hepokur, Ecem Önder Tokuç, Turgay Uçak, Anıl Korkmaz, Mehmet Egemen Karataş, V. Levent Karabaş, İbrahim Koçak, Ece Özal, Sadık Altan Özal, Murat Arıcı, Akın Çakır, Şerife Çiloğlu Hayat, Serhat Ermiş, Murat Karapapak, Nihat Sayın
article en

Abstract

Although early switching yields the greatest visual improvement and faster rehabilitation, it incurs higher costs. The no-switch strategy provided modest visual improvement at the lowest cost, resulting in the most favourable cost-effectiveness ratio. Late switching produced limited benefit at high cost, rendering it an unfavourable option. Treatment decisions should balance clinical efficacy and cost-effectiveness on an individual basis.

Clinical and Experimental Optometry
Tekirdağ Namık Kemal University (TR), Haseki Eğitim ve Araştırma Hastanesi (TR), Memorial Sisli Hospital (TR), Istanbul University-Cerrahpaşa (TR), Beyoglu Goz Egitim ve Arastirma Hastanesi (TR), Bakırköy Dr.Sadi Konuk Eğitim ve Araştırma Hastanesi (TR), Şişli Etfal Eğitim ve Araştırma Hastanesi (TR), İstanbul Kanuni Sultan Süleyman Eğitim ve Araştırma Hastanesi (TR), İstanbul Başakşehir Çam ve Sakura Şehir Hastanesi, Kocaeli Üniversitesi (TR)
Good health and well-being
Openalex Percentile: Top 95%
Retinal Diseases and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.